North America Platelet Rich Plasma Tube Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage (Skin Rejuvenation, Hair Restoration, Orthopedics, Surgical Oncology, Gynecology, and Others), Volume (Less Than 5 ML, 6 ML TO 10 ML, and Mo

North America Platelet Rich Plasma Tube Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Usage (Skin Rejuvenation, Hair Restoration, Orthopedics, Surgical Oncology, Gynecology, and Others), Volume (Less Than 5 ML, 6 ML TO 10 ML, and More Than 10 ML), and End User (MedSpas, Dermatology Offices, Hospitals and Healthcare Practices, Tricologist Practices, and Others)

The North America platelet rich plasma tube market is expected to grow from US$ 261.11 million in 2022 to US$ 642.10 million by 2028. It is estimated to register a CAGR of 16.2% from 2022 to 2028.

Rising Number of Cosmetic and Aesthetic Procedures Drives North America Platelet Rich Plasma Tube Market

Platelet-rich plasma procedures utilize the body’s natural tissue repair process to improve form and function of the body. These procedures are intended for several noninvasive cosmetic skin treatments. The procedure shows promising results in plastic surgery. In aesthetic procedures, platelet-rich plasma is used to improve the texture of the skin; add volume to the face, hands, and neck; treat fine lines and wrinkles around the eyes; minimize wrinkles and lines around the mouth; and treat acne scars and stretch marks. These easy-to-perform procedures are inexpensive as they utilize the cells of patients. Moreover, they are associated with little or no risk of adverse reactions, which propels the adoption of platelet-rich plasma in treatments. The American Society of Plastic Surgeons (ASPS) has produced a report on the use of platelet-rich plasma. According to a survey by the International Society of Aesthetic Plastic Surgery (ISAPS), ~10.1 million surgical procedures (including eyelid surgery, ear surgery, and Liposuction) and ~14.4 million nonsurgical procedures (hair removal, photo rejuvenation, and botulinum toxin) were performed across the world in 2020. In the US, The number of nonsurgical and surgical cosmetic procedures increased significantly by ~1.56 million in 2021. Nonsurgical procedures have considerably outrun surgical procedures. In 2021, over 5.5 million procedures performed across the US involved the use of toxins and fillers. Thus, the North America platelet rich plasma tube market is growing with the rising number of cosmetic and aesthetic procedures performed every year.

North America Platelet Rich Plasma Tube Market Overview

The US dominates the North American economy due to its highly diversified industrial demand. Industries in this country are more flexible in expansion and innovation than those in any other countries in the world. The growing incidence of sports injuries in the US fuels the North America platelet-rich plasma tubes market expansion. Sports are an essential part of the culture in the United States of America. American football is the most popular spectator sport in the US, followed by baseball, basketball, ice hockey, and soccer, respectively, which make the Big Five. According to Johns Hopkins University, ~30 million children and adolescents in the US participate in organized sports. Participants sustain more than 3.5 million injuries each year that result in some time lost in participation. According to data published by the American Orthopaedic Society for Sports Medicine and the US Centers for Disease Control (CDC), more than 3.5 million kids below the age of 14 are estimated to receive medical treatment for sports injuries every year, accounting for ~40% of all sports-related injuries treated in hospitals. By far, the most common injuries are sprains and strains. platelet-rich plasma are widely used to treat sports injuries.

The US is among largest and fastest-growing market for skin aesthetic procedures, which can be attributed to the rising prevalence of skin resurfacing, skin rejuvenation, and hair removal procedures; and psoriasis, scar, warts, and skin tag treatments. Moreover, growing awareness of cosmetic procedures to improve the aesthetic appeal and technological advancements in skin tightening devices drives their adoption. Further, increasing approval of platelet-rich plasma kits is likely to favor the growth of the North America platelet rich plasma tubes market. Fidia Farmaceutici s.p.a., an Italy-based company operating in the US, received US FDA approval in November 2019 for its Fidia platelet-rich plasma Kit, which allows the rapid preparation of autologous platelet rich plasma at the patient’s point of care (PoC).

North America Platelet Rich Plasma Tube Market Revenue and Forecast to 2028 (US$ Million)

North America Platelet rich plasma tube market Segmentation

The North America platelet rich plasma tube market is segmented on the basis of usage, volume, end user, and country.

Based on usage, the North America platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. In 2022, the others segment accounted for the largest market share. The skin rejuvenation segment is further subsegmented into scars, skin aging, acne, skin ulcers, and others.

By volume, the North America platelet rich plasma tube market is segmented into less than 5 ml, 6 ml to 10 ml, and more than 10 ml. In 2022, the more than 10 ml segment accounted for the largest market share.

The North America platelet rich plasma tube market, in terms of end user, is segmented into MedSpas, dermatology offices, hospitals and healthcare practices, tricologist practices, and others. In 2022, the hospitals and healthcare practice segment held the largest share of the market.

Based on country, the North America platelet rich plasma tube market is segmented into the US, Canada, and Mexico. In 2022, the US accounted for the largest share of the market.

AdvaCare Pharma USA LLC, ADVIN HEALTH CARE, BIO-X, Emerging Medical Group LLC, Henso Medical (Hangzhou) Co Ltd, Integrity PLATELET-RICH PLASMA , Juventix Regenerative Medical LLC, and Manso Medical Co Ltd are the leading companies operating in the North America platelet rich plasma tube market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America platelet rich plasma tubes market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America platelet rich plasma tubes market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the platelet rich plasma tubes market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution